Webinar: Randomization and the Limits of Precision Oncology
Publié le
WATCH RECORDED WEBINAR Drug development in oncology is undergoing several changes brought about by precision medicine, which makes it appealing…
Publié le
WATCH RECORDED WEBINAR Drug development in oncology is undergoing several changes brought about by precision medicine, which makes it appealing…
Publié le
Nowadays, drug development in oncology is largely centered on the basic premise of precision medicine, according to which targeted agents…
Publié le
Estimands Framework: Ensuring alignment between the key scientific question of interest, analysis and interpretation during clinical trial design. The estimands…
Publié le
LEARN ON SAMPLE-SIZE RE-ESTIMATION, CONDITIONAL POWER AND THE PROMISING-ZONE METHOD. In this webinar, we will play the part of a sponsor consulting…
Publié le
Learn on history of bias and randomization in oncology clinical trials and how to think about what constitutes persuasive evidence…
Publié le
IDDI and XClinical webinar on the importance and the benefits Clinical Systems Integration WHAT YOU WILL LEARN:
Publié le
Improvements in the treatment of patients with cancer largely depend on clinical trials comparing a new intervention with a previous…
Publié le
IDDI Complimentary Webinar on characteristics of Covid-19 trials and impact of the pandemic on clinical trials The current SARS-CoV-2-induced…
Publié le
Drug development in oncology in the era of precision medicine 08:30am – 09:30am (CET), 19th NOVEMBER, 2020 WATCH THE RECORDED…
Publié le
Recently, Erik Falvey, our Senior Director of Business Development, shared his insights during a Q&A session with Medicon Valley Alliance,…